See All Slides - tctmd.com

Slides

Presentation TCT 2012

The Clinical Business Model for CTO PCI in the United States: Do Procedure Time, Reimbursement, and Costs Preclude Development of CTO PCI Programs?

Presenter: Dimitri Karmpaliotis

October 22, 2012

Presentation TCT 2012

Final 12 Month Outcomes from the SUPERB Trial Using the Supera Woven Nitinol Stent

Presenter: Lawrence Garcia

October 22, 2012

Presentation TCT 2012

Case Resolution(4)

Presenter: Jie Qian

October 22, 2012

Presentation TCT 2012

Introduction(14)

Presenter: Sigmund Silber

October 22, 2012

Presentation TCT 2012

Clinical Pearls from Experienced Valve-in-Valve Operators: Self-Expanding TAVR for Aortic Valve-in-Valve

Presenter: Jean-Claude Laborde

October 22, 2012

Presentation TCT 2012

Complex Left Main PCI Requiring Hemodynamic Support

Presenter: Jan Harnek

October 22, 2012

Presentation TCT 2012

Should Interventionalists Even Assess Post-PCI Biomarkers (CKMB, Troponins, or ECGs)?

Presenter: Allan Jaffe

October 22, 2012

Presentation TCT 2012

Simultaneous Localization and Treatment of Vulnerable Plaque by Tin-117m Conversion Electrons: First-in-Human Results

Presenter: Renu Virmani

October 22, 2012

Presentation TCT 2012

Phase II and III Clinical Trials: Off and Running!

Presenter: Amit Patel

October 22, 2012

Presentation TCT 2012

Uses of Drug-Eluting Balloons for Coronary Bifurcation Lesions: Rationale, Data, and Practice

Presenter: Detlef Mathey

October 22, 2012

Advertisement

Slides

The Clinical Business Model for CTO PCI in the United States: Do Procedure Time, Reimbursement, and Costs Preclude Development of CTO PCI Programs?

Final 12 Month Outcomes from the SUPERB Trial Using the Supera Woven Nitinol Stent

Case Resolution(4)

Introduction(14)

Clinical Pearls from Experienced Valve-in-Valve Operators: Self-Expanding TAVR for Aortic Valve-in-Valve

Complex Left Main PCI Requiring Hemodynamic Support

Should Interventionalists Even Assess Post-PCI Biomarkers (CKMB, Troponins, or ECGs)?

Simultaneous Localization and Treatment of Vulnerable Plaque by Tin-117m Conversion Electrons: First-in-Human Results

Phase II and III Clinical Trials: Off and Running!

Uses of Drug-Eluting Balloons for Coronary Bifurcation Lesions: Rationale, Data, and Practice

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content